1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Cell Analysis Global Market – Forecast To 2020

Cell Analysis Global Market – Forecast To 2020

  • April 2015
  • -
  • IQ4I Research & Consultancy Pvt. Ltd
  • -
  • 423 pages

Cell analysis plays a major role in gene identification, protein identification, transcription analysis and epigenomics at cellular level. It proves to be an ultra-sensitive device to elucidate specific molecular processes and pathways and reveal the nature of cell heterogenecity. Hospitals, academic institutions, government bodies, as well as pharmaceutical and biotechnology firms are increasing their focus on application of cell analysis as a modern emerging tool in research, drug discovery and diagnosis. The cell analysis techniques global market is segmented into molecular approaches, image-based approaches and others. The molecular approaches include the PCR, NGS and Microfluidics, cell isolation & separation techniques performed at cells genomic level, where as the image-based approaches include microscopes, FISH, FRAP, tracking, high content screening (HCS), cytometry techniques etc. The cell analysis products market is mainly segmented into consumables and instruments.

The consumables include reagents, assay plates and microplates where as the instrument segment comprises of microscopes, flow cytometers, --**spectrophotometer, quantitative polymerase chain reaction (QPCR), microfluidic devices, cell counters, high content screening (HCS) systems and cell microarrays.

By application, the market is segmented into by processes, by feild and by therapeutics. By processes is segmented into Cellular processes, Signal transduction pathways, Circulating tumor cells, Single cell analysis, Epigentic target analysis, Subpopulation Characterization, Drug and candidate screening. By field is further segmented into forensic Science, therapeutics, cell imaging, biomarker research, genomic analysis, stem cell analysis, and diagnostics. By therapeutics is further segmented into cancer research, infectious disease diagnosis, genetic testing, immunology, others.

By end-users, the market is segmented into Hospitals, Academic and Research Institutes, Contract Research Organizations (CROs), Pharmaceuticals and Biotechnology Companies, Cell Banks, Diagnostic Laboratories and others.

By geography, the market is segmented into North America, Europe, Asia Pacific and Rest of World. North America holds the largest market share, followed by Europe and Asia. The APAC regions tend to be an emerging market with an opportunity for growth and are likely to be a destination of investment for new investors in the cell analysis market. Drug discovery services outsourcing and government funding for novel screening technologies has resulted in growth of Asian markets.

The cell analysis market is expected to grow at a rate of 9.6% during the forecast period. The major factor influencing the growth is enhanced precision of cell imaging and analysis systems which in turn reduce time and cost of drug discovery process. In addition, the factors like increasing incidence of cancer, increasing government investments, funds and grants, availability of reagents and cell analysis instruments are driving the growth of the market. However, the major market restraints include high capital investments and shortage of skilled labour for high content screening procedure. The biggest opportunities for this market is the emerging APAC market, high content screening services provided by contract research organizations, automation in cancer research for its early diagnosis and reduction of cost in the cancer treatment.

The global cell analysis market is a competitive market and all the active players in this market are involved in innovating new and advanced products to maintain their market shares. The key players in the global cell analysis market include Agilent Technologies, Inc. (U.S.), Becton Dickinson and Company (U.S.), Bio-Rad Laboratories (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.K.), Merck KGAA (Germany), Olympus Corporation (Japan), PerkinElmer, Inc. (U.S.), Promega Corporation (U.S.), Qiagen N.V. (Netherlands), Sigma-Aldrich Corporation (U.S.) and Thermo Fisher Scientific, Inc. (U.S.). In order to offer the products with better software, most of the players in the cell analysis market are collaborating with companies and educational institutions.

Table Of Contents

Cell Analysis Global Market - Forecast To 2020
1 EXECUTIVE SUMMARY 25
2 INTRODUCTION 36
2.1 KEY TAKE AWAYS 36
2.2 REPORT DESCRIPTION 37
2.3 MARKETS COVERED 38
2.4 STAKEHOLDERS 41
2.5 RESEARCH METHODOLOGY 42
2.5.1 MARKET SIZE ESTIMATION 43
2.5.2 MARKET BREAKDOWN and DATA TRIANGULATION 46
2.5.3 SECONDARY SOURCES 47
2.5.4 KEY DATA POINTS FROM SECONDARY SOURCES 48
2.5.5 PRIMARY SOURCES 49
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 49
2.5.7 ASSUMPTIONS 50
3 MARKET ANALYSIS 51
3.1 INTRODUCTION 51
3.2 MARKET SEGMENTATION 52
3.3 FACTORS INFLUENCING MARKET 54
3.3.1 DRIVERS AND OPPORTUNITIES 55
3.3.1.1 Rising incidence of life threatening chronic diseases such as cancer
and infectious diseases 55
3.3.1.2 Increasing government, corporate funding and investment in cell
based research 55
3.3.1.3 Introduction of enhanced and precised cell imaging and analysis system
reduces the cost and time consumption for drug discovery process 56
3.3.1.4 Availability of reagents and advanced cell analysis instruments 56
3.3.1.5 Increasing demand for cell analysis products by end users 57
3.3.1.6 Emerging Asia Pacific cell analysis market 57
3.3.1.7 CRO's to provide HCS services 58
3.3.1.8 Automation in oncology research for early diagnosis and cost reduction
treatments 59
3.3.2 Restraints and Threats 60
3.3.2.1 Patents or IPR issues and stringent regulatory framework limits
advancements in cellular analysis market 60
3.3.2.2 Lack of skilled personnel to perform High Content Screening 60
3.3.2.3 Expensive cell analysis instruments 61
3.4 REGULATORY AFFAIRS 61
3.4.1 U.S. 62
3.4.2 EUROPE 63
3.4.3 CHINA 63
3.4.4 INDIA 63
3.4.5 JAPAN 64
3.5 PORTER'S FIVE FORCE ANALYSIS 64
3.5.1 THREAT OF NEW ENTRANTS 65
3.5.2 THREAT OF SUBSTITUTES 66
3.5.3 RIVALRY AMONG EXISTING COMPETITORS 66
3.5.4 BARGAINING POWER OF SUPPLIERS 67
3.5.5 BARGAINING POWER OF BUYERS 67
3.6 LATEST AND UPCOMING PRODUCTS 67
3.7 ONGOING RESEARCHES AND FUNDING AGENCIES 73
3.8 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 76
4 CELL ANALYSIS GLOBAL MARKET, TECHNIQUES 79
4.1 INTRODUCTION 79
4.2 MOLECULAR APPROACHES 83
4.2.1 PCR (POLYMERASE CHAIN REACTION) 86
4.2.1.1 Real Time PCR/ qPCR 87
4.2.1.2 Digital PCR 87
4.2.2 SEQUENCING 89
4.2.2.1 DNA Sequencing 89
4.2.2.2 Early Methods 89
4.2.2.3 Advanced or De-Novo Sequencing 89
4.2.2.4 Next Generation Methods 90
4.2.2.5 RNA Sequencing 90
4.2.2.6 Protein sequencing 90
4.2.3 MICROFLUIDICS AND MICROARRAYS 92
4.2.3.1 Microfluidics 92
4.2.3.2 Microarray 92
4.2.4 NORTH CELL ISOLATION AND SEPARATION 93
4.2.4.1 Centrifugation 94
4.2.4.1.1 Micro-centrifugation 94
4.2.4.1.2 High-Speed Centrifugation or Super speed centrifugation 94
4.2.4.1.3 Ultra-centrifugation 95
4.2.4.2 Cell surface based separation 95
4.2.4.3 Filtration based cell separation 96
4.3 IMAGE BASED APPROACHES 97
4.3.1 MICROSCOPY 101
4.3.1.1 Optical Microscopy 102
4.3.1.1.1 Fluorescence Microscopy 102
4.3.1.1.1.1 Stimulated Emission Depletion (STED) 103
4.3.1.1.1.2 Total Internal Reflection Fluorescence (TIRF) 103
4.3.1.1.1.3 FRAP (Fluorescence Recovery After Photobleaching) 104
4.3.1.1.1.4 Laser Capture Microdissection 105
4.3.1.1.2 Confocal Microscopy 105
4.3.1.2 Electron microscopy 107
4.3.1.2.1 Scanning Electron Microscope (SEM) 107
4.3.1.2.2 Transmission Electron Microscopy (TEM) 107
4.3.1.2.3 Cryo-Electron Tomography (Cryo-ET) 107
4.3.1.3 Scanning Probe Microscopy (SPM) 108
4.3.2 CYTOMETRY 109
4.3.2.1 Flow cytometry 111
4.3.2.2 Laser scanning cytometry 113
4.3.2.3 Image cytometry 115
4.3.3 HIGH CONTENT SCREENING 116
4.3.4 FISH (FLUOROSCENCE IN-SITU HYBRIDIZATION) 119
4.3.5 SPECTROPHOTOMETRY 121
5 GLOBAL CELL ANALYSIS PRODUCTS MARKET 123
5.1 INTRODUCTION 123
5.2 CONSUMABLES 126
5.2.1 ASSAY KITS 128
5.2.1.1 Immunoassays 129
5.2.1.2 Cell based assays 129
5.2.2 REAGENTS 130
5.2.3 MICROPLATES 132
5.2.4 CELL CULTURE CONSUMABLES 134
5.2.5 OTHERS 135
5.3 INSTRUMENTS 137
5.3.1 CELL COUNTERS 139
5.3.1.1 Hemocytometers 140
5.3.1.2 Automated cell counters 141
5.3.1.3 Coulter counters 141
5.3.1.4 Other cell counters 142
5.3.2 CELL MICROARRAYS 142
5.3.3 CELL ISOLATION AND SEPERATION INSTRUMENTS 144
5.3.4 CYTOMETERS 147
5.3.4.1 Flow cytometers 148
5.3.4.2 Laser scanning cytometers 150
5.3.4.3 Imaging cytometers 151
5.3.5 HIGH CONTENT SCREENING SYSTEMS 152
5.3.5.1 High content screening imaging and analysis system 154
5.3.5.2 High content screening software 155
5.3.6 MICROFLUIDIC DEVICES 156
5.3.7 PCR INSTRUMENTS 158
5.3.8 SPECTROPHOTOMETERS 160
5.3.8.1 Microplate readers 162
5.3.8.2 Fluorescent spectrophotometers 163
5.3.8.3 Calorimeters 163
5.3.9 MICROSCOPES 164
5.3.9.1 Electron microscopes 165
5.3.9.2 Inverted microscopes 166
5.3.9.3 Stereo microscopes 167
5.3.9.4 Fluorescence and confocal microscopes 167
5.3.9.5 Phase contrast microscopes 168
5.3.9.6 Other microscopes 168
5.3.10 OTHER INSTRUMENTS 169
5.4 OTHERS 170
6 GLOBAL CELL ANALYSIS APPLICATIONS MARKET 172
6.1 INTRODUCTION 172
6.2 CELL ANALYSIS APPLICATIONS, BY PROCESS 174
6.2.1 CELLULAR PROCESSES 175
6.2.2 SIGNAL TRANSDUCTION PATHWAY 177
6.2.3 CIRCULATING TUMOR CELLS 178
6.2.4 SINGLE CELL ANALYSIS 180
6.2.5 EPIGENETIC TARGET ANALYSIS 181
6.2.6 SUBPOPULATION CHARACTERIZATION 183
6.2.7 DRUG AND CANDIDATE SCREENING 184
6.3 CELL ANALYSIS APPLICATIONS, BY FIELD 185
6.3.1 FORENSICS 186
6.3.2 THERAPEUTICS 187
6.3.3 GENOMIC ANALYSIS 190
6.3.4 STEM CELL ANALYSIS 191
6.3.5 BIOMARKER RESEARCH 193
6.3.6 CELL IMAGING 194
6.3.7 DIAGNOSTICS 196
6.4 CELL ANALYSIS APPLICATIONS, BY THERAPEUTIC AREA 198
6.4.1 CANCER RESEARCH 199
6.4.2 GENETIC TESTING 200
6.4.3 INFECTIOUS DISEASES 201
6.4.4 IMMUNOLOGY 202
6.4.5 OTHERS 204
7 CELL ANALYSIS GLOBAL MARKET, BY END-USERS 206
7.1 INTRODUCTION 206
7.2 HOSPITALS 208
7.3 ACADEMIC and RESEARCH LABORATORIES 210
7.4 DIAGNOSTIC LABORATORIES 212
7.5 PHARMACEUTICALS AND BIOTECH COMPANIES 213
7.6 CONTRACT RESEARCH ORGANISATIONS 215
7.7 CELL BANKS 216
7.8 OTHERS 217
8 REGIONAL MARKET ANALYSIS 219
8.1 INTRODUCTION 219
8.2 NORTH AMERICA 221
8.2.1 U.S. 223
8.3 EUROPE 233
8.4 ASIA PACIFIC 246
8.5 REST OF THE WORLD 259
9 COMPANY DEVELOPMENTS 271
9.1 INTRODUCTION 271
9.1.1 NEW PRODUCT LAUNCHES AS A MAJOR GROWTH STRATEGY OF CELL ANALYSIS PLAYERS 271
9.2 NEW PRODUCT LAUNCH 272
9.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS and JOINT VENTURES 288
9.4 APPROVALS 296
9.5 MERGERS AND ACQUISITIONS 299
9.6 OTHER DEVELOPMENTS 305
10 MAJOR PLAYER PROFILES 307
10.1 AGILENT TECHNOLOGIES, INC. 307
10.1.1 OVERVIEW 307
10.1.2 FINANCIALS 308
10.1.3 PRODUCT PORTFOLIO 310
10.1.4 KEY DEVELOPMENTS 313
10.1.5 BUSINESS STRATEGY 317
10.1.6 SWOT ANALYSIS 318
10.2 BECTON, DICKINSON AND COMPANY 319
10.2.1 OVERVIEW 319
10.2.2 FINANCIALS 320
10.2.3 PRODUCT PORTFOLIO 322
10.2.4 KEY DEVELOPMENTS 324
10.2.5 BUSINESS STRATEGY 326
10.2.6 SWOT ANALYSIS 327
10.3 BIO-RAD LABORATORIES 328
10.3.1 OVERVIEW 328
10.3.2 FINANCIALS 329
10.3.3 PRODUCT PORTFOLIO 330
10.3.4 KEY DEVELOPMENTS 332
10.3.5 BUSINESS STRATEGY 334
10.3.6 SWOT ANALYSIS 335
10.4 DANAHER CORPORATION 336
10.4.1 OVERVIEW 336
10.4.2 FINANCIALS 337
10.4.3 PRODUCT PORTFOLIO 339
10.4.4 KEY DEVELOPMENTS 345
10.4.5 BUSINESS STRATEGY 348
10.4.6 SWOT ANALYSIS 349
10.5 GE HEALTHCARE 350
10.5.1 OVERVIEW 350
10.5.2 FINANCIALS 351
10.5.3 PRODUCT PORTFOLIO 353
10.5.4 KEY DEVELOPMENTS 358
10.5.5 BUSINESS STRATEGY 360
10.5.6 SWOT ANALYSIS 360
10.6 MERCK KGAA 361
10.6.1 OVERVIEW 361
10.6.2 FINANCIALS 362
10.6.3 PRODUCT PORTFOLIO 364
10.6.4 KEY DEVELOPMENTS 366
10.6.5 BUSINESS STRATEGY 368
10.6.6 SWOT ANALYSIS 369
10.7 OLYMPUS CORPORATION 370
10.7.1 OVERVIEW 370
10.7.2 FINANCIALS 371
10.7.3 PRODUCT PORTFOLIO 373
10.7.4 KEY DEVELOPMENTS 375
10.7.5 BUSINESS STRATEGY 376
10.7.6 SWOT ANALYSIS 377
10.8 PERKINELMER, INC. 378
10.8.1 OVERVIEW 378
10.8.2 FINANCIALS 379
10.8.3 PRODUCT PORTFOLIO 381
10.8.4 KEY DEVELOPMENTS 382
10.8.5 BUSINESS STRATEGY 384
10.8.6 SWOT ANALYSIS 385
10.9 PROMEGA CORPORATION 386
10.9.1 OVERVIEW 386
10.9.2 FINANCIALS 387
10.9.3 PRODUCT PORTFOLIO 387
10.9.4 KEY DEVELOPMENTS 389
10.9.5 BUSINESS STRATEGY 391
10.9.6 SWOT ANALYSIS 392
10.10 QIAGEN N.V. 393
10.10.1 OVERVIEW 393
10.10.2 FINANCIALS 393
10.10.3 PRODUCT PORTFOLIO 395
10.10.4 KEY DEVELOPMENTS 398
10.10.5 BUSINESS STRATEGY 401
10.10.6 SWOT ANALYSIS 402
10.11 SIGMA ALDRICH CORPORATION 403
10.11.1 OVERVIEW 403
10.11.2 FINANCIALS 404
10.11.3 PRODUCT PORTFOLIO 405
10.11.4 KEY DEVELOPMENTS 407
10.11.5 BUSINESS STRATEGY 409
10.11.6 SWOT ANALYSIS 410
10.12 THERMO FISHER SCIENTIFIC, INC. 411
10.12.1 OVERVIEW 411
10.12.2 FINANCIALS 412
10.12.3 PRODUCT PORTFOLIO 414
10.12.4 KEY DEVELOPMENTS 418
10.12.5 BUSINESS STRATEGY 421
10.12.6 SWOT ANALYSIS 422



LIST OF TABLES

TABLE 1 CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 29
TABLE 2 CELL ANALYSIS GLOBAL TECHNIQUES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 30
TABLE 3 CELL ANALYSIS GLOBAL PRODUCTS MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 31
TABLE 4 CELL ANALYSIS GLOBAL APPICATION MARKET REVENUE, BY PROCESS, BY TYPE (2012-2020) ($MN) 32
TABLE 5 CELL ANALYSIS GLOBAL APPICATION MARKET REVENUE, BY FIELD, BY TYPE (2012-2020) ($MN) 33
TABLE 6 CELL ANALYSIS GLOBAL APPICATION MARKET REVENUE, BY THERAPEUTIC AREA, BY TYPE (2012-2020) ($MN) 34
TABLE 7 CELL ANALYSIS GLOBAL END USERS MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 35
TABLE 8 CELL ANALYSIS GLOBAL TECHNIQUES MARKET REVENUE, BY REGION, (2012-2020) ($MN) 81
TABLE 9 CELL ANALYSIS GLOBAL MARKET REVENUE, BY TECHNIQUE, (2012-2020) ($MN) 82
TABLE 10 MOLECULAR APPROACHES CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 85
TABLE 11 CELL ANALYSIS MOLECULAR APPROACHES MARKET REVENUE, BY TYPES, (2012-2020) ($MN) 86
TABLE 12 PCR TECHNIQUE IN CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 88
TABLE 13 SEQUENCING TECHNIQUE IN CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 91
TABLE 14 MICROFLUIDICS and MICROARRAYS IN CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 93
TABLE 15 CELL ISOLATION/ SEPARATION TECHNIQUES IN CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 97
TABLE 16 IMAGE-BASED APPROACHES CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 99
TABLE 17 IMAGE-BASED APPROACHES CELL ANALYSIS GLOBAL MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 100
TABLE 18 MICROSCOPY CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 101
TABLE 19 MICROSCOPY CELL ANALYSIS GLOBAL MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 102
TABLE 20 OPTICAL MICROSCOPY CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 106
TABLE 21 ELECTRON MICROSCOPY CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 108
TABLE 22 SCANNING PROBE MICROSCOPY CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 109
TABLE 23 CYTOMETRY CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 110
TABLE 24 CYTOMETRY CELL ANALYSIS GLOBAL MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 111
TABLE 25 FLOW CYTOMETRY CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 113
TABLE 26 LASER SCANNING CYTOMETRY CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 114
TABLE 27 IMAGE CYTOMETRY SCREENING CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 116
TABLE 28 HIGH CONTENT SCREENING CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 118
TABLE 29 FISH (FLUORESCENT IN-SITU HYBRIDIZATION) CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 120
TABLE 30 SPECTROPHOTOMETRY CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 122
TABLE 31 CELL ANALYSIS GLOBAL PRODUCTS MARKET, BY TYPE (2012-2020) ($MN) 125
TABLE 32 CELL ANALYSIS CONSUMABLES GLOBAL MARKET, BY REGION (2012-2020) ($MN) 126
TABLE 33 CELL ANALYSIS CONSUMABLES GLOBAL MARKET, BY TYPE (2012-2020) ($MN) 127
TABLE 34 CELL ANALYSIS ASSAY KITS GLOBAL MARKET, BY REGION (2012-2020) ($MN) 128
TABLE 35 CELL ANALYSIS REAGENTS GLOBAL MARKET, BY REGION (2012-2020) ($MN) 132
TABLE 36 CELL ANALYSIS MICROPLATES GLOBAL MARKET, BY REGION (2012-2020) ($MN) 133
TABLE 37 CELL ANALYSIS CONSUMABLES MARKET FOR CELL CULTURE, BY REGION (2012-2020) ($MN) 135
TABLE 38 GLOBAL CELL ANALYSIS OTHER CONSUMABLES MARKET, BY REGION (2012-2020) ($MN) 136
TABLE 39 CELL ANALYSIS INSTRUMENTS GLOBAL MARKET, BY REGION (2012-2020) ($MN) 137
TABLE 40 CELL ANALYSIS INSTRUMENTS GLOBAL MARKET, BY TYPE (2012-2020) ($MN) 138
TABLE 41 CELL ANALYSIS CELL COUNTERS GLOBAL MARKET, BY REGION (2012-2020) ($MN) 140
TABLE 42 CELL ANALYSIS CELL MICROARRAYS GLOBAL MARKET, BY REGION (2012-2020) ($MN) 144
TABLE 43 CELL ANALYSIS CELL ISOLATION/ SEPARATION INSTRUMENTS GLOBAL MARKET, BY REGION (2012-2020) ($MN) 146
TABLE 44 CELL ANALYSIS CYTOMETERS GLOBAL MARKET, BY REGION (2012-2020) ($MN) 148
TABLE 45 CELL ANALYSIS HIGH CONTENT SCREENING GLOBAL MARKET, BY REGION (2012-2020) ($MN) 153
TABLE 46 CELL ANALYSIS MARKET FOR MICROFLUIDIC DEVICES, BY REGION (2012-2020) ($MN) 158
TABLE 47 CELL ANALYSIS MARKET FOR PCR DEVICES, BY REGION (2012-2020) ($MN) 160
TABLE 48 CELL ANALYSIS SPECTROPHOTOMETERS GLOBAL MARKET, BY REGION (2012-2020) ($MN) 161
TABLE 49 CELL ANALYSIS MICROSCOPES GLOBAL MARKET, BY REGION (2012-2020) ($MN) 165
TABLE 50 GLOBAL CELL ANALYSIS OTHER INSTRUMENTS MARKET, BY REGION (2012-2020) ($MN) 170
TABLE 51 GLOBAL CELL ANALYSIS OTHER (SERVICES) PRODUCTS MARKET, BY REGION (2012-2020) ($MN) 171
TABLE 52 GLOBAL CELL ANALYSIS APPLICATION MARKET, BY REGION (2012-2020) ($MN) 173
TABLE 53 GLOBAL CELL ANALYSIS APPLICATION MARKET FOR CELLULAR PROCESSES, BY REGION, (2012-2020) ($MN) 176
TABLE 54 GLOBAL CELL ANALYSIS APPLICATION MARKET FOR SIGNAL TRANSDUCTION STUDIES, BY REGION (2012-2020) ($MN) 178
TABLE 55 GLOBAL CELL ANALYSIS APPLICATIONS MARKET FOR CTC, BY REGION (2012-2020) ($MN) 179
TABLE 56 GLOBAL CELL ANALYSIS APPLICATIONS MARKET FOR SINGLE CELL ANALYSIS, BY REGION (2012-2020) ($MN) 181
TABLE 57 GLOBAL CELL ANALYSIS APPLICATIONS MARKET FOR EPIGENETIC TARGET ANALYSIS, BY REGION (2012-2020) ($MN) 182
TABLE 58 GLOBAL CELL ANALYSIS APPLICATIONS MARKET FOR SUBPOPULATION CHARACTERIZATION, BY REGION (2012-2020) ($MN) 183
TABLE 59 GLOBAL CELL ANALYSIS APPLICATIONS MARKET FOR DRUG AND CANDITATE SCREENING, BY REGION (2012-2020) ($MN) 185
TABLE 60 GLOBAL CELL ANALYSIS APPLICATION MARKET RELATED TO FORENSICS, BY REGION, (2012-2020) ($MN) 187
TABLE 61 GLOBAL CELL ANALYSIS APPLICATION MARKET RELATED TO THERAPEUTICS, BY REGION (2012-2020) ($MN) 189
TABLE 62 GLOBAL CELL ANALYSIS APPLICATIONS MARKET FOR GENOMIC ANALYSIS, BY REGION (2012-2020) ($MN) 191
TABLE 63 GLOBAL CELL ANALYSIS APPLICATIONS MARKET FOR STEM CELL ANALYSIS, BY REGION (2012-2020) ($MN) 192
TABLE 64 GLOBAL CELL ANALYSIS APPLICATIONS MARKET FOR BIOMARKER RESEARCH, BY REGION (2012-2020) ($MN) 194
TABLE 65 GLOBAL CELL ANALYSIS APPLICATIONS MARKET FOR CELL IMAGING, BY REGION (2012-2020) ($MN) 196
TABLE 66 GLOBAL CELL ANALYSIS APPLICATIONS MARKET FOR DIAGNOSTICS, BY REGION (2012-2020) ($MN) 197
TABLE 67 GLOBAL CELL ANALYSIS APPLICATION MARKET FOR CANCER RESEARCH, BY REGION, (2012-2020) ($MN) 199
TABLE 68 GLOBAL CELL ANALYSIS APPLICATION MARKET FOR GENETIC TESTING, BY REGION (2012-2020) ($MN) 201
TABLE 69 GLOBAL CELL ANALYSIS APPLICATIONS MARKET FOR INFECTIOUS DISEASES, BY REGION (2012-2020) ($MN) 202
TABLE 70 GLOBAL CELL ANALYSIS APPLICATIONS MARKET FOR IMMUNOLOGY, BY REGION (2012-2020) ($MN) 203
TABLE 71 GLOBAL CELL ANALYSIS APPLICATIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION (2012-2020) ($MN) 205
TABLE 72 CELL ANALYSIS GLOBAL END USERS MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 208
TABLE 73 GLOBAL CELL ANALYSIS MARKET REVENUE FROM HOSPITALS, BY REGION, (2012-2020) ($MN) 210
TABLE 74 GLOBAL CELL ANALYSIS MARKET REVENUE FROM ACADEMICS and RESEARCH LABORATORIES, BY REGION, (2012-2020) ($MN) 211
TABLE 75 GLOBAL CELL ANALYSIS MARKET REVENUE FROM DIAGNOSTIC LABORATORIES, BY REGION, (2012-2020) ($MN) 213
TABLE 76 GLOBAL CELL ANALYSIS MARKET REVENUE FROM PHARMA and BIOTECH COMPANIES, BY REGION, (2012-2020) ($MN) 214
TABLE 77 GLOBAL CELL ANALYSIS MARKET REVENUE FROM CRO'S, BY REGION, (2012-2020) ($MN) 216
TABLE 78 GLOBAL CELL ANALYSIS MARKET REVENUE FROM CELL BANKS, BY REGION, (2012-2020) ($MN) 217
TABLE 79 GLOBAL CELL ANALYSIS MARKET REVENUE FROM OTHER END USERS, BY REGION, (2012-2020) ($MN) 218
TABLE 80 NORTH AMERICAN CELL ANALYSIS TECHNIQUES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 224
TABLE 81 NORTH AMERICAN MOLECULAR APPROACHES MARKET REVENUE, BY TYPES, (2012-2020) ($MN) 225
TABLE 82 NORTH AMERICAN IMAGE BASED APPROACHES MARKET REVENUE, BY TYPES, (2012-2020) ($MN) 226
TABLE 83 NORTH AMERICAN CELL ANALYSIS PRODUCTS MARKET REVENUE, BY TYPE (2012-2020) ($MN) 227
TABLE 84 NORTH AMERICAN CONSUMABLES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 228
TABLE 85 NORTH AMERICAN INSTRUMENTS MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 229
TABLE 86 NORTH AMERICAN APPLICATIONS MARKET REVENUE, BY PROCESSES, BY TYPE, (2012-2020) ($MN) 230
TABLE 87 NORTH AMERICAN APPLICATIONS MARKET REVENUE, BY FIELD, BY TYPE, (2012-2020) ($MN) 231
TABLE 88 NORTH AMERICAN APPLICATIONS MARKET REVENUE, BY THERAPEUTIC AREAS, BY TYPE, (2012-2020) ($MN) 232
TABLE 89 NORTH AMERICAN CELL ANALYSIS END USERS MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 233
TABLE 90 EUROPEAN CELL ANALYSIS TECHNIQUES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 236
TABLE 91 EUROPEAN MOLECULAR APPROACHES MARKET REVENUE, BY TYPES, (2012-2020) ($MN) 237
TABLE 92 EUROPEAN IMAGE BASED APPROACHES MARKET REVENUE, BY TYPES, (2012-2020) ($MN) 238
TABLE 93 EUROPEAN CELL ANALYSIS PRODUCTS MARKET REVENUE, BY TYPE (2012-2020) ($MN) 239
TABLE 94 EUROPEAN CONSUMABLES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 240
TABLE 95 EUROPEAN INSTRUMENTS MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 241
TABLE 96 EUROPEAN APPLICATIONS MARKET REVENUE, BY PROCESSES, BY TYPE, (2012-2020) ($MN) 242
TABLE 97 EUROPEAN APPLICATIONS MARKET REVENUE, BY FIELD, BY TYPE, (2012-2020) ($MN) 243
TABLE 98 EUROPEAN APPLICATIONS MARKET REVENUE, BY THERAPEUTIC AREAS, BY TYPE, (2012-2020) ($MN) 244
TABLE 99 EUROPEAN CELL ANALYSIS END USERS MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 245
TABLE 100 ASIA PACIFIC CELL ANALYSIS TECHNIQUES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 249
TABLE 101 ASIA PACIFIC MOLECULAR APPROACHES MARKET REVENUE, BY TYPES, (2012-2020) ($MN) 250
TABLE 102 ASIA PACIFIC IMAGE BASED APPROACHES MARKET REVENUE, BY TYPES, (2012-2020) ($MN) 251
TABLE 103 ASIA PACIFIC CELL ANALYSIS PRODUCTS MARKET REVENUE, BY TYPE (2012-2020) ($MN) 252
TABLE 104 ASIA PACIFIC CONSUMABLES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 253
TABLE 105 ASIA PACIFIC INSTRUMENTS MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 254
TABLE 106 ASIA PACIFIC APPLICATIONS MARKET REVENUE, BY PROCESSES, BY TYPE, (2012-2020) ($MN) 255
TABLE 107 ASIA PACIFIC APPLICATIONS MARKET REVENUE, BY FIELD, BY TYPE, (2012-2020) ($MN) 256
TABLE 108 ASIA PACIFIC APPLICATIONS MARKET REVENUE, BY THERAPEUTIC AREAS, BY TYPE, (2012-2020) ($MN) 257
TABLE 109 ASIA PACIFIC CELL ANALYSIS END USERS MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 258
TABLE 110 ROW CELL ANALYSIS TECHNIQUES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 261
TABLE 111 ROW MOLECULAR APPROACHES MARKET REVENUE, BY TYPES, (2012-2020) ($MN) 262
TABLE 112 ROW IMAGE BASED APPROACHES MARKET REVENUE, BY TYPES, (2012-2020) ($MN) 263
TABLE 113 ROW CELL ANALYSIS PRODUCTS MARKET REVENUE, BY TYPE (2012-2020) ($MN) 264
TABLE 114 ROW CONSUMABLES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 265
TABLE 115 ROW INSTRUMENTS MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 266
TABLE 116 ROW APPLICATIONS MARKET REVENUE, BY PROCESSES, BY TYPE, (2012-2020) ($MN) 267
TABLE 117 ROW APPLICATIONS MARKET REVENUE, BY FIELD, BY TYPE, (2012-2020) ($MN) 268
TABLE 118 ROW APPLICATIONS MARKET REVENUE, BY THERAPEUTIC AREAS, BY TYPE, (2012-2020) ($MN) 269
TABLE 119 ROW CELL ANALYSIS END USERS MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 270
TABLE 120 NEW PRODUCT LAUNCHES, (2011-2015) 273
TABLE 121 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS and JOINT VENTURE, (2011-2014) 289
TABLE 122 APPROVALS, (2013-2014) 297
TABLE 123 MERGERS AND ACQUISITIONS, (2013-2014) 300
TABLE 124 OTHER DEVELOPMENTS (2013-2014) 305
TABLE 125 AGILENT TECHNOLOGIES, INC.: TOTAL REVENUE AND RandD EXPENSES (2012-2014) ($MN) 308
TABLE 126 AGILENT TECHNOLOGIES, INC.: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN) 309
TABLE 127 AGILENT TECHNOLOGIES, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 310
TABLE 128 BECTON, DICKINSON AND COMPANY: TOTAL REVENUE AND RandD EXPENSES (2012-2014) ($MN) 320
TABLE 129 BECTON, DICKINSON AND COMPANY: TOTAL REVENUE, BY SEGMENTS (2012-2014) ($ MN) 321
TABLE 130 BECTON, DICKINSON AND COMPANY: TOTAL REVENUE, BY GEOGRAPHY (2012-2014) ($ MN) 322
TABLE 131 BIO-RAD LABORATORIES: TOTAL REVENUE AND RandD EXPENSES (2011-2013) ($MN) 329
TABLE 132 BIO-RAD LABORATORIES: TOTAL REVENUE, BY SEGMENTS (2011-2013) ($MN) 329
TABLE 133 BIO-RAD LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY (2011-2013) ($MN) 330
TABLE 134 DANAHER CORPORATION: TOTAL REVENUE AND RandD EXPENSES (2011-2013) ($BN) 337
TABLE 135 DANAHER CORPORATION: TOTAL REVENUE, BY SEGMENTS (2011-2013) ($BN) 338
TABLE 136 DANAHER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2011-2013) ($BN) 339
TABLE 137 GENERAL ELECTRIC COMPANY: TOTAL REVENUE AND RandD EXPENSES (2012 - 2014) ($BN) 351
TABLE 138 GENERAL ELECTRIC COMPANY: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($BN) 352
TABLE 139 GENERAL ELECTRIC COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($BN) 353
TABLE 140 MERCK KGAA: TOTAL REVENUE AND RandD EXPENSES (2012 - 2014) ($MN) 362
TABLE 141 MERCK KGAA: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($BN) 363
TABLE 142 MERCK KGAA: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($BN) 364
TABLE 143 OLYMPUS CORPORATION : TOTAL REVENUE AND RandD EXPENSES (2011-2013) ($MN) 371
TABLE 144 OLYMPUS CORPORATION : TOTAL REVENUE, BY SEGMENTS (2011-2013) ($MN) 372
TABLE 145 OLYMPUS CORPORATION : TOTAL REVENUE, BY REGION (2011-2013) ($MN) 373
TABLE 146 PERKINELMER, INC.: TOTAL REVENUE AND RandD EXPENSES (2012-2014) ($MN) 379
TABLE 147 PERKINELMER, INC.: TOTAL REVENUE, BY SEGMENTS (2012-2014) ($MN) 379
TABLE 148 PERKINELMER, INC.: TOTAL REVENUE, BY GEOGRAPHY (2012-2014) ($MN) 380
TABLE 149 PROMEGA CORPORATION: TOTAL REVENUE AND RandD EXPENSES, (2011-2013) ($MN) 387
TABLE 150 QIAGEN'S: TOTAL REVENUE AND RandD EXPENSES, (2011-2013) ($MN) 393
TABLE 151 QIAGEN'S: TOTAL REVENUE, BY SEGMENTS, (2011-2013) ($MN) 394
TABLE 152 QIAGEN'S: TOTAL REVENUE, BY GEOGRAPHY, (2011-2013) ($MN) 395
TABLE 153 SIGMA ALDRICH'S: TOTAL REVENUE AND RandD EXPENSES, (2012-2014) ($MN) 404
TABLE 154 SIGMA ALDRICH'S: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN) 404
TABLE 155 SIGMA ALDRICH'S: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 405
TABLE 156 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE AND RandD EXPENSES (2011-2013) ($BN) 412
TABLE 157 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY SEGMENTS (2011-2013) ($BN) 413
TABLE 158 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY GEOGRAPHY (2011-2013) ($BN) 414

























LIST OF FIGURES

FIGURE 1 GLOBAL CELL ANALYSIS MARKET SHARE, BY GEOGRAPHY (2012-2020) 28
FIGURE 2 RESEARCH METHODOLOGY: CELL ANALYSIS GLOBAL MARKET 43
FIGURE 3 CELL ANALYSIS MARKET: TOP-DOWN AND BOTTOM-UP APPROACH 44
FIGURE 4 CELL ANALYSIS MARKET: FORECASTING MODEL 45
FIGURE 5 CELL ANALYSIS MARKET: MARKET BREAKDOWN and DATA TRIANGULATION 46
FIGURE 6 GLOBAL CELL ANALYSIS MARKET: MARKET SEGMENTATION 53
FIGURE 7 MARKET DYNAMICS 54
FIGURE 8 CELL ANALYSIS MARKET: PORTER'S ANALYSIS 65
FIGURE 9 GLOBAL CELL ANALYSIS MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2013 76
FIGURE 10 GLOBAL CELL ANALYSIS MARKET REVENUE, BY TECHNIQUE (2013 V'S 2020) ($ MN) 80
FIGURE 11 MOLECULAR APPROACHES CELL ANALYSIS MARKET SHARE, BY TYPE (2013 V'S 2020) (%) 84
FIGURE 12 IMAGE-BASED APPROACHES CELL ANALYSIS GLOBAL MARKET REVENUE, BY TYPE (2013 V'S 2020) ($ MN) 98
FIGURE 13 GLOBAL CELL ANALYSIS MARKET, BY PRODUCT, (2013 V'S 2020), ($MN) 124
FIGURE 14 GLOBAL CELL ANALYSIS APPLICATION MARKET SHARE, BY PROCESS OUTLOOK WITH CAGR (2012-2020) ($MN) 175
FIGURE 15 GLOBAL CELL ANALYSIS APPLICATION MARKET, BY FIELD OUTLOOK (2013) ($MN) 186
FIGURE 16 GLOBAL CELL ANALYSIS APPLICATION MARKET, BY THERAPEUTIC AREA OUTLOOK (2012-2020) ($MN) 198
FIGURE 17 GLOBAL CELL ANALYSIS MARKET REVENUE, BY END USERS (2012-2020) ($MN) 207
FIGURE 18 GLOBAL CELL ANALYSIS MARKET REVENUE, BY REGION (2014-2020) ($MN) 220
FIGURE 19 OUTLOOK OF NORTH AMERICAN MARKET SIZE, BY PRODUCTS, APPLICATIONS, TECHNIQUES and END-USERS (2013 and 2020) 222
FIGURE 20 OUTLOOK OF EUROPEAN MARKET SIZE, BY PRODUCTS, APPLICATIONS, TECHNIQUES and END-USERS (2013 and 2020) 235
FIGURE 21 OUTLOOK OF ASIA PACIFIC MARKET SIZE, BY PRODUCTS, APPLICATIONS, TECHNIQUES and END-USERS (2013 and 2020) 248
FIGURE 22 OUTLOOK OF ROW MARKET SIZE, BY PRODUCTS, APPLICATIONS, TECHNIQUES and END-USERS (2013 and 2020) 260
FIGURE 23 KEY GROWTH STRATEGIES, (2011-2014) 271
FIGURE 24 SWOT ANALYSIS: AGILTENT TECHNOLOGIES. INC, 318
FIGURE 25 SWOT: BECTON, DICKINSON AND COMPANY 327
FIGURE 26 SWOT: BIO-RAD LABORATORIES 335
FIGURE 27 SWOT: DANAHER CORPORATION 349
FIGURE 28 SWOT: GE HEALTHCARE 360
FIGURE 29 SWOT: MERCK KGAA 369
FIGURE 30 SWOT: OLYMPUS CORPORATION 377
FIGURE 31 SWOT: PERKINELMER, INC. 385
FIGURE 32 SWOT: PROMEGA CORPORATION 392
FIGURE 33 SWOT: QIAGEN N.V 402
FIGURE 34 SWOT: SIGMA ALDRICH CORPORATION 410
FIGURE 35 SWOT: THERMO FISHER SCIENTIFIC 422

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Single-Cell Analysis - Global Market Outlook (2016-2022)

Single-Cell Analysis - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Single-Cell Analysis market is estimated at $1.22 billion in 2015 and is expected to reach $4.25 billion by 2022 growing at a CAGR of 19.5% from 2015 to 2022. Growing ...

Global and Chinese Cell Analysis Industry, 2016 Market Research Report

Global and Chinese Cell Analysis Industry, 2016 Market Research Report

  • $ 2800
  • Industry report
  • November 2016
  • by Prof Research

The 'Global and Chinese Cell Analysis Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Cell Analysis industry with a focus on the Chinese ...

Global Cell Analysis Market 2016-2020

Global Cell Analysis Market 2016-2020

  • $ 2500
  • Industry report
  • September 2016
  • by Infiniti Research Limited

About Cell Analysis Cell analysis helps identify and map many of the basic biochemical and physical processes of life. Bio-specimen preparation, cell and tissue separation, and characterization products ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.